Figure 1: The formononetin treatment reduced the incidence of lung cancer and decreased the expression of COX-2 in mice. (A) The body weight of mice in each group, the mice in blank group received no treatment, in control group received urethane treatment, and in formonone group received urethane treatment and formonone treatment. (B) The incidence of lung cancer in mice at week 15 and 20 after urethane treatment. (C-D) COX-2-positive rate in lung tissues of mice at week 15 and 20 after urethane treatment.
Figures at a glance